IDEXX Labs (NASDAQ: IDXX) reported Q3 EPS of $2.79, $0.11 better than the analyst estimate of $2.68. Revenue for the quarter came in at $975.54 million versus the consensus estimate of $979.98 million.

GUIDANCE:

IDEXX Labs sees FY2024 EPS of $10.37-$10.53, versus the consensus of $10.81. IDEXX Labs sees FY2024 revenue of $3.865-3.89 billion, versus the consensus of $3.918 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.